Genelux Corporation

NASDAQ:GNLX

Biotechnology

Healthcare
$2.24 +2.63%

+$0.08 today

Market cap
$107.66M
Beta
0.55
P/E (TTM)
-3.0
EPS (TTM)
-$0.98
52W Low $2.29High $8.54

Volume 0.80M

Average 0.19M

Balance Sheet

Inspect the capital base behind the business.

Assets

$19.03M

FY 2025 · Annual

-45.2% YoY

Liabilities

$7.48M

FY 2025 · Annual

-11.4% YoY

Equity

$11.54M

FY 2025 · Annual

-56.1% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents4.5M397K9.42M8.57M5.33M
Short-term Investments0013.77M22.33M9.26M
Net Receivables00000
Inventory00000
Other Current Assets1.33M1.5M1.01M653K535K
Total Current Assets5.82M1.89M24.2M31.55M15.13M
Property, Plant & Equipment (Net)2.21M1.98M3.6M3.08M3.75M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets92K1.66M92K92K144K
Total Non-current Assets2.3M3.64M3.69M3.17M3.9M
Total Assets8.13M5.53M27.89M34.72M19.03M
Account Payables4.46M6.78M3.78M5.57M4.36M
Short-term Debt6.16M16.4M653K329K0
Tax Payables00000
Deferred Revenue4.5M170K000
Other Current Liabilities4.11M5.16M000
Total Current Liabilities22.48M31.63M6.55M6.9M6.23M
Long-term Debt18.02M8.52M000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities18.75M9.69M1.87M1.54M1.26M
Total Liabilities41.24M41.31M8.42M8.44M7.48M
Common Stock9K9K27K35K38K
Retained Earnings(184.58M)(189.78M)(221.52M)(251.39M)(283.54M)
Accumulated OCI2K2K14K64K9K
Other Stockholders Equity00000
Minority Interest00000
Total Equity(33.11M)(35.78M)19.47M26.27M11.54M
Total Debt25.31M26.35M2.52M1.87M1.69M
Net Debt20.82M25.96M(6.9M)(6.7M)(3.65M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$9.3M
Short-term Investments$16.9M
Other Current$545.0K
Total Current Assets$26.8M
PP&E (Net)$5.5M
Other Non-current$144.0K
Total Non-current Assets$5.6M
Total Assets$32.4M

Analysis

Selected assets total $32.4M for Latest. The largest visible component is Short-term Investments at $16.9M, about 52.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 5, 2026
4Statement of changes in beneficial ownershipNov 5, 2026
4Statement of changes in beneficial ownershipNov 5, 2026
SC 13G/ASC 13G/A filingNov 4, 2026
4Statement of changes in beneficial ownershipSep 2, 2026

How much cash does GNLX have?

Genelux Corporation (GNLX) reported $5.33M in cash and equivalents in fiscal 2025.

How much debt does GNLX carry?

Genelux Corporation (GNLX) reported $1.69M of total debt, with net debt of -$3.65M.